Status:
COMPLETED
Craving, Binge Eating and Obesity
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Binge Eating Disorder
Obesity
Eligibility:
FEMALE
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
This research study is designed to look at the effectiveness of bupropion for reducing binge eating in overweight persons with binge eating problems. Participants in the study will receive either bupr...
Detailed Description
The proposed study is an 8-week randomized placebo-controlled trial to test the efficacy of bupropion in treating overweight women with binge eating disorder (BED). Bupropion is an antidepressant that...
Eligibility Criteria
Inclusion
- BMI 25-50
- Able to travel to clinical site (New Haven, CT) for bi-weekly visits.
Exclusion
- Predisposition to seizures
- History of anorexia or bulimia nervosa
- Current Type I or Type II diabetes mellitus
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00414167
Start Date
December 1 2005
End Date
March 1 2011
Last Update
April 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University School of Medicine
New Haven, Connecticut, United States, 06520